• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment.

作者信息

Moonen L, vd Voet H, de Nijs R, Hart A A, Horenblas S, Bartelink H

机构信息

Department of Radiotherapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis, Amsterdam.

出版信息

Radiother Oncol. 1998 Nov;49(2):149-55. doi: 10.1016/s0167-8140(98)00089-9.

DOI:10.1016/s0167-8140(98)00089-9
PMID:10052880
Abstract

PURPOSE

To determine the relationship between tumour and patient characteristics and local control and survival for patients with T2 and T3 bladder cancer treated with radical external beam radiotherapy and to evaluate the predictive value of cystoscopic response evaluation during radiation on final outcome.

MATERIALS AND METHODS

Records from 379 patients with non-metastasized T2 or T3 transitional cell carcinoma of the bladder were reviewed. All patient received external beam radiotherapy at The Netherlands Cancer Institute during the period from 1977 to 1990. The total dose varied from 50 to 75 Gy with a mean of 60.5 Gy and a median of 60.4 Gy. The median follow-up was 22 months for all patients and 82 months for the 30 patients still alive at last follow-up. A stepwise procedure using proportional hazard regression was used to identify prognostic factors with respect to local recurrence and survival.

RESULTS

One hundred thirty-six patients experienced a local recurrence and 120 of these occurred before regional or distance metastases. The actuarial results at 5 years were 40.3% local control (SE 4.0%), 24.9% disease-free rate (SE 3.0%) and 22.2% overall survival (SE 2.2%). In the univariate analysis age, performance status, result of intravenous pyelography (IVP) and T-stage were found to be related to overall survival and multifocality was related to local control. Multivariate analysis revealed that only age and T-stage were related to survival and only multifocality was related to local control. In patients with solitary tumours who were identified as having the most favourable outcome. local control was 50% at 5 years. Local control in 89 patients who had a cystoscopic evaluation during treatment was identical regardless of whether a complete, partial or no response was observed. Furthermore, local control was identical in patients selected on the basis of a favourable response and in unselected patients.

CONCLUSIONS

Although we identified some significant prognostic factors, their predictive value is not strong enough to allow accurate estimation of treatment effect and disease outcome. Cystoscopic response evaluation during treatment was found not to provide reliable information to direct further treatment. Prospective studies to identify ways to select patients for bladder conservation using definitive radiotherapy are urgently needed.

摘要

相似文献

1
Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment.
Radiother Oncol. 1998 Nov;49(2):149-55. doi: 10.1016/s0167-8140(98)00089-9.
2
Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control.采用外照射放疗治疗肌层浸润性膀胱癌:总剂量、总治疗时间及治疗中断对局部控制的影响
Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):525-30. doi: 10.1016/s0360-3016(98)00263-6.
3
Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors.
Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):267-77. doi: 10.1016/0360-3016(94)90004-3.
4
Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique.根治性放射治疗和挽救性膀胱切除术作为膀胱移行细胞癌的主要治疗方法。引入CT规划技术后的结果。
Clin Oncol (R Coll Radiol). 2002 Apr;14(2):141-7. doi: 10.1053/clon.2002.0055.
5
Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.肌层浸润性膀胱癌的局部控制:术前放疗联合膀胱切除术与单纯膀胱切除术的比较。
Int J Radiat Oncol Biol Phys. 1995 May 15;32(2):331-40. doi: 10.1016/0360-3016(95)00086-E.
6
Treatment results of radiation therapy for muscle-invasive bladder cancer.肌层浸润性膀胱癌放射治疗的疗效。
Strahlenther Onkol. 2010 Apr;186(4):203-9. doi: 10.1007/s00066-010-2053-1. Epub 2010 Mar 26.
7
Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.肌层浸润性膀胱癌的术前放疗。338例患者的长期随访及预后因素
Cancer. 1994 Nov 15;74(10):2819-27. doi: 10.1002/1097-0142(19941115)74:10<2819::aid-cncr2820741013>3.0.co;2-l.
8
Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.顺铂与多西他赛同步化疗联合外照射根治性放疗用于浸润性移行细胞膀胱癌患者:耐受性及局部控制的初步报告
Anticancer Res. 1997 Nov-Dec;17(6D):4771-80.
9
[Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].[顺铂与同期放疗对无法手术切除的膀胱癌进行长期治疗的结果:局部控制和生存的预后因素]
Cancer Radiother. 1998 Apr;2 Suppl 1:85s-91s.
10
Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer.接受膀胱癌根治性放疗患者的局部控制和生存的治疗结果及预后变量。
Acta Oncol. 2004;43(8):749-57. doi: 10.1080/02841860410018629.

引用本文的文献

1
Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer.肌肉浸润性膀胱癌治疗中的膀胱保留方案。
Transl Androl Urol. 2020 Dec;9(6):2920-2937. doi: 10.21037/tau.2020.02.10.
2
The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer.采用实时肿瘤追踪放疗系统行保留膀胱的三联疗法治疗肌层浸润性膀胱癌的最新结果。
Jpn J Clin Oncol. 2020 May 5;50(5):609-616. doi: 10.1093/jjco/hyz211.
3
Bladder Preservation Therapy: Review of Literature and Future Directions of Trimodal Therapy.
膀胱保留疗法:文献综述及三联疗法的未来方向
Curr Urol Rep. 2018 Nov 3;19(12):108. doi: 10.1007/s11934-018-0859-z.
4
Landmarks in the treatment of muscle-invasive bladder cancer.肌层浸润性膀胱癌的治疗里程碑。
Nat Rev Urol. 2017 Sep;14(9):565-574. doi: 10.1038/nrurol.2017.82. Epub 2017 Jul 4.
5
Bladder Preservation for Muscle Invasive Bladder Cancer.肌肉浸润性膀胱癌的膀胱保留术
Bladder Cancer. 2016 Apr 27;2(2):151-163. doi: 10.3233/BLC-150025.
6
Outcome following radical cystectomy and bladder-preservation therapy in patients with invasive carcinoma of urinary bladder.浸润性膀胱癌患者行根治性膀胱切除术及膀胱保留治疗后的结果。
Indian J Urol. 2008 Jan;24(1):48-53. doi: 10.4103/0970-1591.38603.
7
GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.葡萄糖转运蛋白1(GLUT1)和碳酸酐酶IX(CAIX)作为膀胱癌缺氧的内在标志物:与血管生成和增殖的关系作为加速放疗联合化疗(ARCON)疗效的预测指标
Br J Cancer. 2003 Oct 6;89(7):1290-7. doi: 10.1038/sj.bjc.6601260.